The FreeStyle Libre 2 requires the sensor to be scanned for readings to update. Both Dexcom systems can be programmed to work ...

If consumers find their sensor is from one of the affected lots ... products such as the FreeStyle Libre 14 day, FreeStyle ...

Both of Abbott's over-the-counter CGMS are based on its popular FreeStyle Libre sensor technology ... It was designed for people with Type 2 diabetes and prediabetes in mind, so they can see ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Some better-ranked stocks in the broader medical space are TransMedix Group TMDX, Veracyte VCYT and Boston Scientific BSX. While TransMedix Group and Veracyte currently sport a Zacks Rank #1 (Strong ...

Users wear a small sensor inserted in their body ... given her more flexibility Abbott has come under fire after its Libre 2 CGM stopped interacting with the LibreLink app of some Apple users.

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Earlier this year, Abbott integrated its FreeStyle Libre 2 Plus sensor with Tandem’s t:slim X2 insulin pump and Insulet received a CE mark for the integration of its Omnipod 5 pump with the company’s ...

The planned launch of Omnipod 5 with Abbott's Freestyle Libre 2 Plus sensor is likely to drive further growth in the U.S. markets.

The planned launch of Omnipod 5 with Abbott's Freestyle Libre 2 Plus sensor is likely to drive further growth in the U.S. markets. Alcon, Inc. (NYSE: ALC) delivered core earnings per share of 74 ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetesWith a single sensor, the ...